scholarly journals First Chapters of Yearly Reports of International Committee of Drug Control

Narkokontrol ◽  
2010 ◽  
Vol 2 ◽  
pp. 16-17
Author(s):  
A.V. Fedorov ◽  

The article presents information on the activity of the International Committee of Drug Control with regard to preparation of yearly reports and recommendations for governments, UNO, UN Department for Drugs and Crime, World Health Organization and other international and regional organizations related to the issues of drug control.

2021 ◽  
Vol 7 (1) ◽  
pp. 24-32
Author(s):  
Semen Kireev ◽  
I. Popov ◽  
A. Ban'kovskiy ◽  
E. Litvinenko ◽  
E. Surova

At the end of 2019, an outbreak of a new coronavirus infection occurred in the People's Re-public of China with an epicenter in the city of Wuhan (Hubei province). On February 11, 2020, the World Health Organization has assigned the official name of the infection caused by the new coronavirus - COVID-19 ("Coronavirus disease2019"). On February 11, 2020, the International Committee on Virus Taxonomy gave the official name to the infectious agent - SARS-CoV-2.Since the end of January 2020, cases of COVID-19 have begun to be registered in many coun-tries of the world, mainly associated with travel to the PRC. At the end of February 2020, the epidemiological situation with COVID-19 in South Korea, Iran and Italy sharply worsened, which subsequently led to a significant increase in the number of cases in other countries of the world associated with travel to these countries, incl. and in Russia. The World Health Organiza-tion announced the COVID-19 pandemic on 11 March 2020, and the pandemic's challenge to the world will remain so as long as people are not immune to it.The Regional Director of the World Health Organization Takeshi Kasai, on the basis of an epidemiological analysis, reports that the spread of coronavirus infection COVID-19 in July-August 2020 occurred mainly among people under 50 years old, and they often did not even know about it, because they had mild or no symptoms. In the future, these people then infect older people who are more difficult to tolerate COVID-19. And we need to redouble our efforts to prevent the spread of the virus in vulnerable communities.


1961 ◽  
Vol 15 (2) ◽  
pp. 309-313 ◽  

The Executive Board of the World Health Organization (WHO) held its 26th session in Geneva from October 25 to November 4, 1960, under the chairmanship of Dr. H. M. Penido. Dr. M. G. Candau, Director-General of WHO, reported on WHO assistance to the Republic of the Congo (Leopoldville) deriving from the request of the Secretary-General and the Security Council in July 1960 that WHO take part in the UN emergency program in the Congo. Twenty-eight WHO staff members had immediately been assigned to the Congo, and within a few weeks 28 medical teams had been sent by 25 national Red Cross, Red Crescent, and Red Lion and Sun Societies as the result of an appeal by WHO to the International Committee of the Red Cross and the League of Red Cross Societies. These teams made it possible to get a number of hospitals operating again in the cities and in the interior. To meet the long-range medical needs of the Congo where there were as yet no native doctors, assistants medicaux were selected for further training and given WHO fellowships to attend medical schools so that they might become fully qualified doctors. To cope with the crisis the UN guaranteed the funds necessary for WHO to engage 130 health workers of all categories to work for the Congolese government. Dr. Candau concluded his report by emphasizing that, if political stability and normal administration could be effectuated, the medical problems of the Congo would not be difficult to solve; the preventative work carried out under the Belgian administration could then be resumed and the threat of the spread of disease effectively averted.


Author(s):  
Ravinder Singh Nagi ◽  
Satinder Pal Singh ◽  
Prahlad Duggal

<p class="Noindentpara">A new virus was reported for causing a spurt of pneumonia cases in Wuhan, Hubei 56 province in China in December 2019. This coronavirus, was initially named as the 2019- novel coronavirus (2019-nCoV) on 12 January 2020 by World Health Organization (WHO). WHO officially named the disease as coronavirus disease 2019 (COVID- 19) and coronavirus study group (CSG) of the International Committee proposed to name the new Coronavirus as SARS-CoV-2, both issued on 11 February 2020.</p>


1997 ◽  
Vol 78 (6) ◽  
pp. 901-912 ◽  
Author(s):  
Christine D. Thomson ◽  
Andrew J. Colls ◽  
John V. Conaglen ◽  
Matthew Macormack ◽  
Martin Stiles ◽  
...  

The aims of this study were (1) to compare various measures of I status, and (2) to assess urinary I and thyroid hormone status of residents of two areas of New Zealand where, before the iodization of salt, goitre was endemic due to low soil I. A total of 189 subjects (102 males, eighty-seven females) were recruited from the Dunedin Blood Transfusion Centre, and 144 (sixty-seven males, seventyseven females) from the Waikato Blood Transfusion Centre between November 1993 and June 1994. Blood was taken for thyroid hormone assays, and subjects collected a fasting overnight urine specimen, a double-voided fasting urine sample, and a complete 24 h specimen for iodide and creatinine analyses. Positive correlations (P < 0.0001) between daily iodide excretion and iodide concentrations in fasting and double-voided fasting urines, identical median values for iodide concentrations in the three samples, and similar numbers of subjects classified as at risk from I deficiency disorders according to the International Committee for the Control of Iodine Deficiency Disorders/World Health Organization categories (World Health Organization, 1994) confirmed indications from earlier studies that fasting urine samples were suitable for population studies. However 24 h urinary iodide excretion remains the recommended measure for individual I status. Waikato residents excreted more iodide in urine and all measures were significantly greater than for Otago residents. However median urinary iodide excretions for both areas (60 and 76 μg/d for Otago and Waikato respectively) were considerably lower than those reported previously for New Zealand. Thyroid hormone concentrations were within normal ranges. Our findings suggest that I status of New Zealanders may no longer be considered adequate and may once again be approaching levels of intake associated with clinical I deficiency.


1981 ◽  
Vol 21 (222) ◽  
pp. 158-158

Indian Prime Minister, Mrs. Indira Gandhi, visited on May 6 the headquarters of the International Committee of the Red Cross in Geneva following her address to the Assembly of the World Health Organization.


Sign in / Sign up

Export Citation Format

Share Document